We think Onsemi will continue to outgrow its underlying markets by selling greater dollar content into applications like electric vehicles and renewable energy applications, which also helps partially ...
Q4 2024 Management View CEO Chris Kempczinski noted that 2024 performance fell short of expectations due to external challenges, including pressure on consumer spending and a food safety incident in ...
Itochu stock remains strong despite recent lag, with growth investments and profit forecasts driving optimism. Read more ...
Although the addressable market for AI is enormous, not everyone is sold on the success of a pair of market-leading ...
Corteva's genetically modified Enlist platform has had wins over Bayer in recent years in gaining approval for its GMO seeds to be imported into China, which should boost Enlist's market share.
Strong performances by AstraZeneca and mining stocks today helped the FTSE 100 index set a new record above 8700.
CEO Kevin Hykes highlighted strong revenue growth of $15.3 million for Q4 2024, representing a 36% increase year-over-year. U.S. Heart Failure revenues grew by 41%, supported by the expansion to 48 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results